Financial Position - As of September 30, 2025, the company had cash of $1,001,325 and a working capital deficit of $357,128[223]. - As of September 30, 2025, the company did not have any off-balance sheet arrangements[243]. Net Loss - For the three months ended September 30, 2025, the company reported a net loss of approximately $1,300,000, primarily due to a loss from the change in fair value of derivative liabilities of approximately $1.1 million[228]. - For the nine months ended September 30, 2025, the company had a net loss of approximately $1,700,000, which included a loss from the change in fair value of derivative liabilities of approximately $1.0 million[230]. - For the three months ended September 30, 2024, the company had a net income of approximately $326,000, driven by gains from the change in fair value of derivative liabilities of approximately $882,000[229]. Business Operations - The company has until November 15, 2026, to consummate an initial Business Combination, after which it must cease operations and redeem Public Shares if not completed[225]. - The company has determined that its liquidity condition raises substantial doubt about its ability to continue as a going concern[226]. Derivative Liabilities - The fair value of converted loans as of September 30, 2025, was $57,500, included in contingently issuable private placement warrants[224]. - The company recognized 22,050,000 warrants as derivative liabilities, which are subject to re-measurement at each balance sheet date until exercised[233]. Regulatory Classification - The company is classified as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new or revised accounting standards[244]. - No quantitative and qualitative disclosures about market risk are required for smaller reporting companies[246].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42607 DUNE ACQUISITION CORPORATION II (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or othe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42607 DUNE ACQUISITION CORPORATION II (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or othe ...

Revenue Performance - Revenue for the three months ended September 30, 2025 totaled $2.4 million, a decrease of $2.0 million or 45% compared to $4.4 million for the same quarter in the prior year[329]. - Revenue for the nine months ended September 30, 2025 totaled $8.1 million, a decrease of $4.6 million or 36% compared to $12.8 million for the same period in the prior year[335]. - The Company experienced a 36% decline in revenue for the nine months ended September 30, 2025, totaling $8,142,000 compared to $12,756,000 in 2024[374]. - Total revenue decreased by $2.0 million, or 45%, to $2.4 million compared to $4.4 million in the prior year quarter[377]. - Total revenue for the nine months ended September 30, 2025, decreased by $4.6 million, or 36%, to $8.1 million compared to $12.8 million in the prior year period[378]. Cost and Expenses - Cost of revenue for the three months ended September 30, 2025 decreased $1.4 million, or 50% to $1.3 million, compared to $2.7 million in the comparable prior year quarter[330]. - Cost of revenue for the nine months ended September 30, 2025 decreased $3.1 million, or 40% to $4.6 million, compared to $7.7 million in the comparable prior year period[336]. - Total operating expense for the three months ended September 30, 2025 decreased $1.0 million, or 20% to $4.1 million, compared to $5.2 million in the comparable prior year quarter[333]. - Total operating expense for the nine months ended September 30, 2025 decreased $3.8 million, or 22% to $13.4 million, compared to $17.3 million in the comparable prior year period[337]. - Selling, marketing and advertising expense decreased by $698,000, or 29%, primarily due to a $914,000 reduction in personnel costs[384]. - Engineering, technology and development expense decreased by $247,000, or 27%, driven by a $436,000 reduction in product and engineering personnel costs[387]. - General and administrative expenses for the three months ended September 30, 2025, decreased by $170,000 (9%) compared to the same period in 2024, totaling $1,765,000[389]. - Total general and administrative expenses for the nine months ended September 30, 2025, decreased by $1,620,000 (25%) to $4,938,000 compared to the same period in 2024[389]. Net Loss - Net loss for the three months ended September 30, 2025 was $3.6 million, compared to a net loss of $3.6 million in the comparable prior year quarter[333]. - Net loss for the nine months ended September 30, 2025 was $10.6 million or $(4.96) per share, compared to a net loss of $11.3 million, or $(80.10) per share, in the comparable prior year period[337]. - The net loss from operations for the three months ended September 30, 2025, was $3,051,000, a 12% improvement from a loss of $3,453,000 in the same period of 2024[374]. Financing Activities - The Company entered into Securities Purchase Agreements for a PIPE Offering, raising approximately $20 million for various corporate purposes[342]. - The Company completed equity financings totaling $20.0 million in gross proceeds in October 2025, providing significant additional working capital[410]. - The Company achieved a net cash provided by financing activities of $5.6 million for the nine months ended September 30, 2025, compared to $1.3 million in 2024, indicating a significant increase of over 330%[420]. - The Company raised approximately $670,000 from the May III Offering by selling 79,750 shares at $4.80 per share, closing on June 2, 2025[454]. - The Company utilized net proceeds from the May I Offering, totaling approximately $700,400, for working capital and to repay a portion of its indebtedness[458]. Asset Management - Cash and cash equivalents totaled $1.1 million as of September 30, 2025, down from $1.3 million at December 31, 2024[409]. - The company reported a net decrease in cash of $249,000 for the nine months ended September 30, 2025, compared to a decrease of $7.3 million in 2024[414]. - The company capitalized software development costs of $200,000 during the nine months ended September 30, 2025, compared to $434,000 in 2024[417]. Strategic Partnerships and Acquisitions - The acquisition of Supersocial expanded the Company's partnerships and included multiple live branded games on Roblox, enhancing its engagement with brands[354]. - The Company expanded its partnership with Meta-Stadiums Corp. to unlock new revenue opportunities within the TikTok creator ecosystem[357]. - The Company sold 100% of the membership interests of InPvP for $350,000, retaining rights to ad sales and brand integration for two years[355][356]. Stock and Equity Transactions - The Company converted $1.0 million of debt into 1.0 million shares of common stock at $1.00 per share as part of the Belleau Exchange Agreement[347]. - The Company issued 2,333,057 Series B Warrants with an exercise price of $1.00, which will be exercisable starting one year after issuance[349]. - The Company increased its authorized shares of Common Stock from 400 million to 750 million through the Third Amended and Restated Certificate of Incorporation[351]. Legal and Compliance - The Company regained compliance with NASDAQ Listing Rule 5550(a)(2) regarding minimum bid price requirements on July 8, 2025[367]. - The Company reported stockholders' equity of $170,000 in its Annual Report for the year ended December 31, 2024, which was below the $2,500,000 requirement[371]. - The company assesses collectability of receivables based on past transaction history and customer creditworthiness, impacting revenue recognition timing[470]. Market and Risk Assessment - The company is not currently exposed to market risks from interest rate changes or foreign currency exchange rates[481]. - The company qualifies as a "smaller reporting company," allowing it to take advantage of exemptions from certain reporting requirements[477]. - The company ceased being an "emerging growth company" as of December 31, 2024, but continues to be a smaller reporting company[480].

Financial Performance - Revenue for the three months ended September 30, 2025 totaled $2.4 million, a decrease of $2.0 million or 45% compared to $4.4 million for the same period in 2024[329] - Revenue for the nine months ended September 30, 2025 totaled $8.1 million, a decrease of $4.6 million or 36% compared to $12.8 million for the same period in 2024[335] - Total revenue decreased by $2.0 million, or 45%, to $2.4 million compared to $4.4 million in the prior year quarter[377] - The Company experienced a 36% decrease in revenue for the nine months ended September 30, 2025, totaling $8,142,000 compared to $12,756,000 in 2024[374] - Media and advertising revenue decreased by $513,000, or 33%, to $1.0 million compared to $1.5 million in the prior year quarter[377] - Publishing and content studio revenue decreased by $1.2 million, or 47%, to $1.4 million compared to $2.6 million in the prior year quarter[377] - Media and advertising revenue for the nine months ended September 30, 2025 decreased by $864,000, or 19%, to $3.8 million compared to $4.6 million in the prior year period[378] - Publishing and content studio revenue for the nine months ended September 30, 2025 decreased by $3.3 million, or 45%, to $4.1 million compared to $7.4 million in the prior year period[378] Cost and Expenses - Cost of revenue for the three months ended September 30, 2025 decreased $1.4 million, or 50% to $1.3 million, compared to $2.7 million in the prior year quarter, resulting in a gross profit margin of 45%[330] - Total operating expense for the three months ended September 30, 2025 decreased $1.0 million, or 20% to $4.1 million, compared to $5.2 million in the prior year quarter[333] - Cost of revenue for the nine months ended September 30, 2025 decreased $3.1 million, or 40% to $4.6 million, compared to $7.7 million in the prior year period[336] - Total operating expense for the nine months ended September 30, 2025 decreased $3.8 million, or 22% to $13.4 million, compared to $17.3 million in the prior year period[337] - Selling, marketing and advertising expense decreased by $698,000, or 29%, for the three months ended September 30, 2025[384] - Engineering, technology and development expense decreased by $247,000, or 27%, for the three months ended September 30, 2025[387] - General and administrative expenses for the three months ended September 30, 2025, decreased by $170,000 (9%) compared to the same period in 2024, totaling $1,765,000[389] - Total general and administrative expenses for the nine months ended September 30, 2025, decreased by $1,620,000 (25%) compared to the same period in 2024, totaling $4,938,000[389] Net Loss and Cash Flow - Net loss for the three months ended September 30, 2025 was $3.6 million, unchanged from the net loss of $3.6 million in the comparable prior year quarter[333] - The Company reported a net cash used in operating activities of $6.8 million for the nine months ended September 30, 2025, compared to $8.2 million for the same period in 2024, reflecting a decrease of approximately 17%[414] - The company reported net cash provided by financing activities of $5.6 million for the nine months ended September 30, 2025, compared to $1.3 million for the same period in 2024[420] Workforce and Cost Reduction - The company executed a 35% workforce reduction in April 2025, which is expected to reduce fiscal year operating costs by approximately $2.7 million through December 31, 2025[324] - The company achieved a 29% reduction in operating expenses for the three months ended September 30, 2025, and a 24% reduction for the nine months ended September 30, 2025, compared to the same periods in 2024[412] Financing Activities - On October 22, 2025, the company entered into Securities Purchase Agreements for a PIPE Offering, raising approximately $20 million before deducting offering costs[342] - The company issued a $4.5 million Convertible Note with an annual interest rate of 8%, scheduled to commence amortization in January 2026[326] - The Company completed equity financings totaling $20.0 million in gross proceeds in October 2025, providing significant additional working capital and liquidity[410] - The Company raised approximately $670,000 from the May III Offering by selling 79,750 shares at $4.80 per share, closing on June 2, 2025[454] - The May II Offering generated net proceeds of approximately $380,000 from the sale of 104,167 shares at a public price of $4.80 per share[456] Asset Sales and Acquisitions - The Company sold 100% of the membership interests of InPvP for $350,000, retaining rights to ad sales and brand integration for two years[355][356] - The Company sold its Mineville assets for cash consideration totaling $350,000, with no gain or loss recognized[392] - The company recorded a gain on the sale of Minehut assets totaling $144,000 for the three and nine months ended September 30, 2024[394] - The company recognized additional gains on the sale of Minehut assets totaling $343,000 for the nine months ended September 30, 2025[394] - The acquisition of Supersocial expanded the Company's partnerships and included multiple live branded games on Roblox[354] Stock and Equity - The Company increased its authorized shares of Common Stock from 400 million to 750 million through an amended certificate[351] - The Company issued 2,333,057 Series B Warrants with an exercise price of $1.00, exercisable after one year from issuance[349] - The Company has the right to direct Yield Point to purchase up to $20,000,000 in shares of common stock under the YP Equity Purchase Agreement[459] Compliance and Reporting - The Company regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) on July 8, 2025[367] - The stockholders' equity reported in the Annual Report for the year ended December 31, 2024, was $170,000, which did not meet the $2,500,000 requirement for continued listing on the Nasdaq Capital Market[371] - The company qualifies as a "smaller reporting company," allowing it to take advantage of certain reporting exemptions[477] - The company expects to utilize reporting exemptions until it no longer qualifies as a smaller reporting company[479] - The company ceased being an "emerging growth company" as of December 31, 2024, but continues to be a smaller reporting company[480] Revenue Recognition and Accounting Policies - The Company generates revenue from innovative advertising, content and technology, and direct-to-consumer offers[468] - Revenue is recognized when the Company transfers promised goods or services to customers, reflecting the consideration expected in exchange[469] - The company assesses the collectability of receivables based on past transaction history and customer creditworthiness, impacting revenue recognition timing and amounts[470] - Significant judgments and estimates are required to determine revenue arrangements, which can materially affect financial results[472] - The fair value of certain promissory notes is measured at estimated fair value on a recurring basis, impacting other comprehensive income and interest expense[473] - The estimated fair value adjustments for promissory notes are recognized in other income (expense) and interest expense, reflecting market fluctuations[474] - The company uses the Black-Scholes option pricing model to determine the fair value of warrants, with significant judgments affecting financial results[476]

Financial Position - As of September 30, 2025, Eledon Pharmaceuticals reported estimated cash, cash equivalents, and short-term investments of approximately $93.4 million[6] Clinical Trials - The company announced results from its Phase 2 BESTOW trial evaluating tegoprubart for the prevention of organ rejection in kidney transplant patients[9] - A conference call is scheduled for November 7, 2025, to discuss updated Phase 2 BESTOW clinical data[10]

Financial Performance - The company generated total revenue of nil for the three months ended September 30, 2025, and had net losses of $22,421,596, compared to net losses of $4,345,724 for the same period in 2024[330]. - For the nine months ended September 30, 2025, the company reported total revenue of nil and net losses of $51,257,996, compared to net losses of $22,689,705 in 2024[330]. - A loss of $22,421,596 was reported for the three months ended September 30, 2025, compared to a loss of $4,345,724 in the same period in 2024[401]. - Revenue decreased by $142,827 during the nine months ended September 30, 2025, compared to the same period in 2024, primarily due to cost reduction measures including employee furloughs[414]. - For the nine months ended September 30, 2025, the company incurred a net loss of $51,257,996, compared to a net loss of $22,689,705 for the same period in 2024, resulting in an accumulated deficit of $172,666,551[441]. Expenses and Cost Management - The operating loss for the nine months ended September 30, 2025, included $10,398,050 of non-cash interest expense recognized on remeasurement of the preferred stock liability[331]. - The company has initiated cost-reduction measures, including employee furloughs, due to funding challenges[329]. - Research and development expenses decreased by $206,474 to $0, primarily due to a reduction in stock-based compensation and personnel costs related to employee furloughs[402]. - Selling and marketing expenses increased by $677,334 to $790,779, driven by higher professional and consulting expenses as part of the Transformation Plan[403]. - General and administrative expenses rose by $86,723 to $1,883,497, influenced by increased professional services and decreased rent expenses[404]. - Interest expense decreased by $1,041,202 to $35,405, mainly due to lower interest-bearing debt balances[405]. - A loss of $1,282,284 was recorded in the change in fair value of warrant liabilities during the nine months ended September 30, 2025, compared to a gain of $2,156,186 in the same period in 2024[422]. - A loss of $1,211,173 was recorded in the change in fair value of notes payable during the nine months ended September 30, 2025, primarily due to an increase in fair value upon conversion of certain notes[424]. - A loss of $2,584,724 was recorded related to the change in fair value of claims settlement liability during the nine months ended September 30, 2025, driven by a reduction in the probability of payment[426]. - A loss of $8,756,303 was recorded on the issuance of warrants during the nine months ended September 30, 2025, related to the excess initial fair value over net proceeds received[427]. Financing and Capital Structure - The company completed a public offering on September 16, 2025, raising gross proceeds of $11,994,884 from 32,373,536 shares of Common Stock and associated warrants[354]. - Net cash proceeds from the Offering amounted to $10,744,346, intended for phased acquisitions and working capital[356]. - The Standby Equity Purchase Agreement allows the company to sell up to $100 million of Common Stock over 36 months[360]. - The company fully extinguished Junior Notes and Senior Notes during the first quarter of 2025 as part of a foreclosure process[363]. - The company plans to finance its operations through the issuance and sale of debt or equity securities, as cash flows from operations are insufficient to fund current operating models and expansion plans[443]. Strategic Acquisitions and Investments - The company entered into a commitment letter to acquire a controlling interest in Tekne and Orbit, with an expected enterprise value of Tekne at $60 million[339]. - The company planned to provide EUR 40 million in financing for Tekne's working capital needs over the next 12 months, including EUR 10.5 million in cash financing and EUR 30 million in inventory monetization[340]. - The company is making up to a $5.0 million equity investment in Orbit as part of the Orbit Acquisition, which includes an aggregate purchase price of $12.5 million[348]. - The company has agreed to consummate the Equity Infusion in tranches, with the first tranche of $1.5 million paid, resulting in a 10.7% ownership interest in Orbit[349]. - The company will acquire full ownership of Orbit from Vanguard in tranches, with an Advance Payment of $3.75 million, including $1.35 million offset and $2.4 million in cash[350]. - The Maddox Joint Venture aims to develop military drones for NATO and commercial applications, with NUBURU Defense contributing up to $10 million[352]. Compliance and Regulatory Issues - The company received a Notice of Noncompliance from NYSE Regulation for not maintaining stockholders' equity of $2.0 million or more[369]. - A reverse stock split of 1-for-40 was executed on July 23, 2024, following stockholder approval[375]. Cash Flow and Liquidity - As of September 30, 2025, the company had cash and cash equivalents of $5,941,542, a significant increase from $209,337 as of December 31, 2024[440]. - Net cash used in operating activities was $7,084,481 for the nine months ended September 30, 2025, compared to $5,499,839 for the same period in 2024[451]. - The company reported net cash provided by financing activities of $17,649,221 for the nine months ended September 30, 2025, compared to $3,583,214 for the same period in 2024[454]. - The company incurred a loss on debt extinguishment of $11,597,803 for the nine months ended September 30, 2024, due to the reacquisition value of the debt being higher than the carrying value[434]. - The company recorded a loss on impairment of inventories, property and equipment, and operating lease right-of-use asset of $6,064,823 related to write-downs and impairments[437]. Future Outlook - The company expects to incur significant expenses and operating losses for the foreseeable future as it implements its Transformation Plan and related acquisitions[332]. - The company expects to incur net losses for the foreseeable future and raises substantial doubt about its ability to continue as a going concern unless it implements its Transformation Plan[442].

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 (Name of registrant as specified in its charter) (State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.) 2100 West Loop South, Suite 900 Houston, Texas 77027 (Address of principal executive offices (Zip Code) Nevada 82-2318545 OR ☐ TRANSITION R ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2025 OMNIQ CORP. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation) Delaware 001-40768 20-3454263 (Commission File Number) (I.R.S. Employer Identification No.) 696 West Confluence Ave. Murray, UT 84123 (Address of Principal Executi ...

Financial Performance - Atmos Energy recorded a net income of $1,198.8 million for fiscal 2025, an increase of $155.9 million from $1,042.9 million in fiscal 2024, reflecting positive rate outcomes driven by safety and reliability spending [138]. - Operating revenues for the fiscal year ended September 30, 2025, increased to $4,425,397, a rise of 13.0% compared to $3,915,141 in 2024 [149]. - Net income for the fiscal year ended September 30, 2025, was $746,781, reflecting a 11.2% increase from $671,413 in 2024 [149]. - Operating income for the distribution segment rose by 12.8% to $963,390 in 2025, driven by a $184.1 million increase in rate adjustments and $26.7 million from residential customer growth [150][153]. - The pipeline and storage segment's operating income increased by 19.1% to $596,581 in 2025, supported by a $100.5 million rise in Mid-Tex/Affiliate transportation revenue [163]. - Total operating revenues for the pipeline and storage segment reached $1,065,300 in 2025, up from $938,029 in 2024, marking a 13.6% increase [162]. Capital Expenditures - The company anticipates capital expenditures of approximately $26 billion between fiscal years 2026 and 2030, with over 80% dedicated to safety and reliability [133]. - Capital expenditures for fiscal 2025 were $3.6 billion, with approximately 87% invested to improve safety and reliability of distribution and transportation systems [142]. - Capital expenditures for the fiscal year ended September 30, 2025, totaled $3.6 billion, up from $2.9 billion in 2024, with a significant increase in distribution segment spending of $413.4 million [175]. Debt and Financing - The company completed approximately $1.8 billion of long-term debt and equity financing during fiscal 2025, maintaining an equity capitalization of 60.3% [143]. - As of September 30, 2025, long-term debt was $8,918.9 million, representing 39.7% of total capitalization, while shareholders' equity was $13,558.9 million, accounting for 60.3% [169]. - The company issued approximately $1.8 billion in net proceeds from long-term debt and equity during the fiscal year ended September 30, 2025 [177]. - Financing activities provided $1,406.8 million in cash for fiscal year 2025, a decrease from $1,478.6 million in 2024 [176]. Liquidity and Cash Flow - As of September 30, 2025, Atmos Energy had approximately $4.9 billion in total liquidity, including $202.7 million in cash and cash equivalents [143]. - For the fiscal year ended September 30, 2025, cash flow from operating activities was $2,049.5 million, an increase of 18.2% compared to $1,733.7 million in 2024 [173]. - The company has a $1.5 billion commercial paper program and $3.1 billion in total availability from revolving credit facilities to support liquidity [166]. Regulatory and Legislative Impact - Texas legislation effective in Q3 of fiscal 2025 positively impacted results by $26.2 million, contributing to the overall net income increase [139]. - Ratemaking regulatory actions implemented during fiscal 2025 resulted in an increase in annual operating income of $333.6 million, excluding the impact of tax refunds [140]. - The distribution segment achieved a $256.4 million increase in annual operating income due to completed regulatory proceedings, with total fiscal 2025 annualized rate outcomes of $245.6 million [145]. Market and Operational Factors - The distribution segment's performance is influenced by the ability to earn authorized rates of return and competitive factors in the energy industry [144]. - Consolidated distribution sales volumes were 289,065 MMcf in 2025, a slight increase from 283,977 MMcf in 2024 [149]. - The average cost of gas sold per Mcf increased to $6.41 in 2025, up from $5.71 in 2024, representing a 12.3% rise [149]. Risk Management - The company is exposed to commodity price risk, but distribution operations have limited exposure due to cost recovery mechanisms [194]. - Short-term interest rate risk is managed through a sensitivity analysis, indicating that a hypothetical 1% increase in interest rates would not materially increase interest expenses in 2025 [195]. - The company employs risk management strategies in its distribution segment to mitigate natural gas price volatility during the winter heating season [193]. Financial Instruments and Fair Value - The fair value of financial instruments decreased from $88,651,000 at September 30, 2024, to $3,412,000 at September 30, 2025, reflecting a significant decline [188]. - Contracts realized/settled amounted to $(130,755,000), while new contracts contributed $5,181,000 to the fair value [188]. - The total fair value of contracts at September 30, 2025, included $(1,036,000) for contracts maturing in less than 1 year and $4,448,000 for contracts maturing in 1-3 years [188]. - The fair value of contracts at September 30, 2025, was primarily based on actively quoted prices, with no contributions from models or other valuation methods [188]. Compliance and Ratings - The company's credit ratings are A- from S&P and A2 from Moody's, with a stable outlook from both agencies [181]. - The company maintained compliance with all debt covenants as of September 30, 2025 [183]. Other Financial Obligations - Total contractual obligations as of September 30, 2025, amounted to $17,689.3 million, with $537.4 million due within one year [185]. - The company was committed to purchase 73.4 Bcf of gas within one year and 114.9 Bcf within two to three years under indexed contracts as of September 30, 2025 [186]. - Cash dividends increased due to an 8.1% rise in the dividend rate and an increase in shares outstanding during fiscal year 2025 [177]. Accounting Developments - Recent accounting developments have been documented in Note 2 of the consolidated financial statements, impacting financial position and cash flows [189]. - The company has liabilities associated with uncertain tax positions, which do not include potential interest and penalties [191]. - Interest charges related to finance lease payments totaled $15.8 million, while operating lease payments included interest of $68.2 million [191].